مرور Volume 17, Issue 1 بر اساس موضوع "ALK"

  • EGFR Mutations, ROS1, and ALK Rearrangements in Iranian Non-Small Cell Lung Cancer Patients 

    Salimi, Babak؛ Mabani, Maryam؛ Seifi, Sharareh؛ Rostami, Parsa؛ Dehghanifard, Ali؛ Khosravi, Negin؛ Madadkar Borna, Marziye؛ Jamali, Elaheh Sadat؛ Shiari, Sarah؛ Sattari, Hanieh؛ Khosravi, Adnan (Tehran, Iranian Blood and Cancer Society, 2025-03-01)
    Background: Driver mutations, particularly in the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and ROS1 genes, are prevalent in non-small cell lung cancer (NSCLC) and significantly influence ...